Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.

Cancer research - 1 Mar 1995

Bernhard H, Disis M L, Heimfeld S, Hand S, Gralow J R, Cheever M A

Abstract excerpt

Dendritic antigen-presenting cells are considered to be the most effective stimulators of T cell immunity. The use of dendritic cells has been proposed to generate therapeutic T cell responses to tumor antigens in cancer patients. One limitation is that the number of dendritic cells in peripheral blood is exceedingly low. Dendritic cells originate from CD34+ hematopoietic progenitor cells (HPC) which are present...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Bone Marrow
Share to Cells, Cultured

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Histocompatibility Antigens Class II

Share to Lymphocyte Activation

Share to Macrophages

Share to Peptide Fragments

Share to Phenotype

Source

Identifiers

PMID: 7532543

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.PMID 7532543Read ↗

Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.Semantic proximity Read ↗

The equivalents of human blood and spleen dendritic cell subtypes can be generated in vitro from human CD34(+) stem cells in the presence of fms-like tyrosine kinase 3 ligand and thrombopoietin.Semantic proximity Read ↗

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.Semantic proximity Read ↗

In vitro generation of murine myeloid dendritic cells from CD34-positive precursors.Semantic proximity Read ↗

Dendritic antigen-presenting cells from the peripheral blood of renal-cell-carcinoma patients.Semantic proximity Read ↗

Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients.Semantic proximity Read ↗

Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4.Semantic proximity Read ↗

Functional antigen presenting cells generated from human dendritic cells (DC) derived induced pluripotent stem cell linesSemantic proximity Read ↗

Phenotypic and functional differences between human dendritic cells derived in vitro from hematopoietic progenitors and from monocytes/macrophages.Semantic proximity Read ↗

Feeder-free generation of functional dendritic cells from human pluripotent stem cellsSemantic proximity Read ↗

Immunophenotypical and functional characterization of bone marrow derived dendritic cells.Semantic proximity Read ↗

Generation of mature dendritic cells with unique phenotype and function by in vitro short-term culture of human monocytes in the presence of interleukin-4 and interferon-beta.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.